But this is provider-specific and not standard practice
However, there are a few things you can do to speed up the process and minimize discomfort
Gland Pharma Limited FY25 Results: Margins Hold Strong, Strategy Gathers Steam Financial Highlights: - FY25 Revenue: 5,617 Cr (1% YoY) - EBITDA Margin: 1,269 Cr (5% YoY) | Margin 23% - PAT: 698 Cr (10% YoY) | Margin at 12% - Dividend: 18/share final dividend recommended Business Highlights: - 31 product launches in FY25, including new molecules like Latanoprost & Dexamethasone - 32 ANDA approvals, 24 filings U.S
PDRN, or Polydeoxyribonucleotide, is a natural compound derived from DNA fragments, often from salmon sperm, known for its regenerative and anti-inflammatory properties
These differences, rather than the drug itself, could account for a portion of the observed risk reduction